Search All News
Amyloid sparks an alliance between two proteins in the brain that can potentially explain up to half of the gene changes that occur in Alzheimer’s.
Multiple sclerosis (MS) usually begins between the ages of 20 and 40 and is the most common disabling neurological disorder of young adults.
Columbia researchers have discovered how a genetic defect leads to spinal muscular atrophy, a finding that could lead to a new therapy for a disease that affects 1 in 6,000 children.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
- May 21, 2014
A study of long-acting injectable antipsychotics for people with schizophrenia found that newer medication was no more effective than older, less expensive medication.
- May 20, 2014
Recent research at Columbia has shed light on an important risk marker for Alzheimer’s—"white matter hyperintensities" (WMH).
- May 15, 2014
Those with both migraine and vascular risk factors may want to pay even greater attention to lifestyle changes that can reduce stroke risk.
- May 15, 2014
NYP/CUMC promotes awareness of and offers expertise in a rare genetic disorder that causes tuberous growths in vital organs.
- May 13, 2014
Racial disparities in stroke are due primarily to higher rates and poorer treatment of hypertension, diabetes, and high cholesterol among black Americans.
- May 5, 2014
NewYork-Presbyterian and Columbia experts discuss ways to recognize and prevent strokes.
- April 30, 2014
Researchers have identified two types of neurons that enable the spinal cord to control skilled forelimb movement. The findings could lead to new ways to treat movement disorders.
- April 20, 2014
Researchers from CUMC, Weill Cornell, and Brandeis have devised a new approach to the treatment of Alzheimer's involving the retromer protein complex.
- April 18, 2014
Dr. Richard Mayeux dispels common misconceptions, and explains the basics, about Alzheimer's disease.
- April 17, 2014
New findings that overturn a theory about the brain and the immune system suggest Parkinson's may be an autoimmune disease.